-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TyQu+EjvPnLZpw13RySfSMhuHWAfmvbrvvHZBb/gc2EaOdH7e1sRkYM/D2HoLRR2 TvWXnEQ7sPJJhpTbSJTiZw== 0001270062-08-000010.txt : 20080219 0001270062-08-000010.hdr.sgml : 20080218 20080219152200 ACCESSION NUMBER: 0001270062-08-000010 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080219 DATE AS OF CHANGE: 20080219 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANGIOTECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001096481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78858 FILM NUMBER: 08626360 BUSINESS ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NATCAN INVESTMENT MANAGEMENT INC CENTRAL INDEX KEY: 0001270062 IRS NUMBER: 137396289 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1100 UNIVERSITY STREET 2: STE 400 CITY: MONTREAL STATE: A8 ZIP: H2B 2G7 BUSINESS PHONE: 514-871-7600 MAIL ADDRESS: STREET 1: 1100 UNIVERSITY STREET 2: STE 400 CITY: MONTREAL STATE: A8 ZIP: H2B 2G7 SC 13G/A 1 anpi0712.txt ANGIOTECH PHARMACEUTICALS INC. - TEXT FILE U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) Angiotech Pharmaceuticals Inc. / CN/ - ------------------------------------------------ (Name of Issuer) Common Shares - ------------------------------------------------ (Title of Class of Securities) 034918102 - ------------------------------------------------ (CUSIP Number) December 31, 2007 - ------------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 034918102 1) Names of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) Natcan Investment Management Inc. 2) Check The Appropriate Box If a Member of a Group (See Instructions) (A) [ ] (B) [ ] 3) SEC Use Only 4) Citizenship or Place of Organization Province of Quebec (Canada) Number of Shares Beneficially Owned by Each Reporting Person With: 5) Sole Voting Power 5,597,624 6) Shared Voting Power 0 7) Sole Dispositive Power 5,597,624 8) Shared Dispositive Power 0 9) Aggregate Amount Beneficially Owned by Each Reporting Person 5,597,624 10) Check If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11) Percent of Class Represented by Amount in Row (9) 6.58% 12) Type of Reporting Person (See Instructions) IA Item 1. (a) Name of Issuer: Angiotech Pharmaceuticals Inc. (b) Address of Issuer's Principal Executive Offices: 1618 Station Street Vancouver, British Columbia V6A 1B6 Canada Item 2. (a) Name of Person Filing: Natcan Investment Management Inc. (b) Address of Principal Business Office or, if none, Residence: 1100 University, Suite 400 Montreal, Quebec H3B 2G7 Canada (c) Citizenship: Canada (d) Title of Class of Securities: Common Shares (e) CUSIP Number: 034918102 Item 3. If this statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is: (a) [ ] Broker or dealer registered under Section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F) (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(ii)(G) (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (j) [ ] Group, in accordance with 13d-1(b)(1)(ii)(J) [X] If this statement is filed pursuant to 13d-1(c), check this box Item 4. Ownership: (a) Amount Beneficially Owned: 5,597,624 (b) Percent of Class: 6.58% (c) Number of Shares as to which such person has: (i) Sole power to vote or direct the vote: 5,597,624 (ii) Shared power to vote or direct the vote: 0 (iii) Sole power to dispose or direct the disposition of: 5,597,624 (iv) Shared power to dispose or direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [ ] Item 6. Ownership of More than Five Percent on Behalf of Another Person: Natcan Investment Management Inc. acts as an investment advisor on behalf of many institutional clients. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company n/a Item 8. Identification and Classification of Members of the Group n/a Item 9. Notice of Dissolution of Group n/a Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Natcan Investment Management, Inc. By: /s/ Christina Milonopoulos Title: Manager, Legal Affairs Date: February 19, 2008 SC 13G/A 2 anpi0712.pdf ANGIOTECH PHARMACEUTICALS INC. - PDF FILE begin 644 anpi0712.pdf M)5!$1BTQ+C0-)>+CS],-"C$W(#`@;V)J/#PO2%LU-38@,3DV72],:6YE87)I M>F5D(#$O12`W,S(Y+TP@,3DW-C')E9@T*,`T*)25%3T8- M"B`@("`@("`@("`@("`-"C$Y(#`@;V)J/#PO3&5N9W1H(#$Q-B]&:6QT97(O M1FQA=&5$96-O9&4O3"`Q,CZF0=-`'(;&!@X@)0& M`X,@3!F0R\W`8-T#I+D@;"!08N!A_1`N7;B?@>$RSP6MFE/>[`)@"1X&!AMY M(,T$Q-8``08`CO84[0T*96YD7!E+T-A=&%L;V'1=+T5X=$=3=&%T93P\+T=3,2`R-R`P(%(^/CX^#65N9&]B M:@TR,B`P(&]B:CP\+U1Y<&4O1F]N="]%;F-O9&EN9R]7:6Y!;G-I16YC;V1I M;F7!E+T9O;G1$97-C2A4:6UE'1'4W1A=&4O4T$@9F%L*`J2V,JD0E)V^N_[%I"2+,?UI8L](^`!#\!;OK?P MXLU,B74[^GX^NIC/M5!BOAJIP`^T"."?9RH)?*U%`E0BYG>CBTD;BZ(ECD"T M134:`U]@M)@7(YR%P/8P^B0_>./(CZ7OC4,_D3,WBMETPAL?O,`/Y7LFKCT- MF_/KZ4QV/B9K*O7X@J606`-Y(2G ML*6D$-XXECJ(^%28\8)"%RA<4*YY,&B*HT` M/1.Y<4MB=K17[)EHD"B]L?:-)&XW)Z86E4ZEF'[!-Q)9N*MR]]B:EXD7?73) MHA2>YKMPK6:>54^KC!=,R".K"\]D@+ACBZ*Y#FX$)Y.VM_+RSGH)2%@M[VS5 MB9O:%^&MQ]<`I$.&=.CKP,1TH4F>=%%P;-N3)7.TA#(&<7SFAV#`OG+8OZS6 M9=W9PHL!HQOQRR:G68/VC.2=!ZC6,B_LOBN+?-N*ZZKPA;@0$_"^DC?(%LL+ MYWV(OR0*'\-'FT&'3W(\!FO^VS^]MZ(L31][2YG>)('NG763@^(8YE;4*W3_ M==N"][0$^"F"3BJ;WGO&-ZG1)TH_[;,3!\$IE80O<-"DOG->J"LQV^2-;9VU M(;)C"*S_J;4A'+4YR3:L8-8KJ,/>W/.RVX*E.;NM(*E!\$ZV>=NZ2#Q:GEE, M`;C0E%UIV]X)D'&C-'G."?-O>]-K7T(>)48\%4^$A&66]P2`[9FFN;&$)X$8N;".,>HU>UT&0##`'R;/'8?M_ M@3DH>JBJQ[4\&NQN>K-?Y1W!'!(1X5E+*M?3>UZR%8^=^'7#L[)P$^)[;S\S MM7>[X$.(@SX?H/,@Y*#5&608JJYQJ>V'V^`,TL52X M4(]\MVOJ75-"B8+:U;F-1?T%-[M:+&U;KBMT!ALN\0.5'MDM2(<<1;Z3<+EH M]I"C=ONFW>=0OU'6Q(]3'1^=T^%@;Q=J7.E6$K7P#*2.'BB0:Y\%QJ%+ZDO"N0`?40"#`J2` MLB3$$E(BUR!H MO^G$"F">8.%7T(?B5.1X!<_YT`[/-,SOM("%-8ED&Y8%62J\Y!N0,.J5&(PZ M/NW^M(LVSH]&0GN1;S'4^H4U#P+:,$Z;!M/FJF[N4#/X]GHH^W6P<[OCJ2TZ MT=5NN?/P0\,QD5G:/1.+WW',B+V@U@<?4G;_+;.%VTEK[D/N]YK#H.O)R@`G+")TL_[52)6-0V-NR/G@\P!IGP`N2*"C:_<*GR(@1@;%)%WZ_V6[U^*G$3< M$A_?9(F[>2J6R$!#O>CK\+*$6`7MBRV-9)]4MN2:/1/@/B+%#I[08+N0X(3S M>^;@.Y9,6(*;(P1O5<3-P,52E!V>XNO`B'RA=?0NIVO6UG]9$AWW790K.>Y3 M4;L'M4X#9SWNFRL8N#^L#I\+H[(8'Z(B[ MSP-Q,A<\9!ABX=4AL;B3$#9%??^(9<=T#AY7'&O#IFC=P7R[%963IL-+%Z=\ M7OQ4!1CWQ=09JL:!;Q=G=?"*4*E[YM@V>"-_XM"=%/MB^H7)PK'D%8]K=X+A M\RBO#:V(=M7U$C(+?\RJ#`^&\)'#(Z[=RE?`\`H+F!,[!)QJRG=,0>[BS!6R MN:$`/)2M%9S!0LI@D4MW3AO@%-LR7_`<,BFIX^Y;\>T]9]YAN@/[5`>A3CF? MR(!?Z[HVW'59@4HC3/:\T!&2<(9(6C@NUSJTC@D5B7M%/`:=:^,Z+Y#]W=PZ M1GZ0),>]HQZ^;T.7CP':#9[1$C$?892T9-NZ:ZU[YC58TAYB8=P+>1829Q@YN.VF][IM;SV7D*;ST5\# M`"VTP)\*#0IE;F1S=')E86T-96YD;V)J#3(Y(#`@;V)J/#PO3&5N9W1H(#(U M-S4O1FEL=&5R+T9L871E1&5C;V1E+TX@,R]!;'1E.G1O>=\YCG:Q`J-5H&S M*6>=0J,P\6F<5]<9E3@CJ3AWU:F5]3A?Q=FERJA1X_S<%*M1RFH!0.DFNT$I M+\?9#V>Z/B=+@O,"`,ATU3M<^@X;E`T&TZ4DU;I&O5I5;L#SM.3S+F>0?P+;VT_YU<]"H!X%J_-^K>VTBT`C*\$P/+F6YO+^P`P\;X= MOOC.??BF>2DW&'1AOK[U]?4^:J7&W6*M0& M=;464VO_4Q-_9=A/-#_7N+ACKP&OV`>P+O(`\K<+`.72`%*T#=^!WO0ME9(' M,O`UW^'>_-S/"?KW4^$^TZ-6K9J+DV3E8'*COFY^S_19`@*@`B;@`2M@#YR! M.Q`"?Q`"PD$TB`?)(!WD@`*P%,A!.=``/:@'+:`==($>L!YL`L-@.Q@#N\%^ M!P_!H_`^^#!\`CX/7X,GX8?P M+`(0&L)''!$A(D8D2#I2B)0A>J05Z48&D5%D/W(,.8M<02:11\@+E(AR40P5 MHN%H$IJ+RM$:M!7M18?17>AA]#1Z!9U"9]#7!`;!EN!%""-("8L(*D(]H8LP M2-A)^(APAG"-,$UX2B02^40!,8281"P@5A";B;W$K<0#Q./$2\2[Q%D2B61% M\B)%D-)),I*!U$7:0MI'^HQTF31->DZFD1W(_N0$8C%H7EQI*P9*Q6U@CK*.L&:Y;-98O8Z6P-NY>]AWV.?9]#XKAQXCD* M3B?G`\XISETNPG7F2KAR[@KN&/<,=YI'Y`EX4EX%KX?W6]X$;\:<8QYHGF?> M8#YB_HGY)!_AN_&E_"I^'_\@_SK_I86=18R%TF*-Q7Z+RQ;/+&TLHRV5EMV6 M!RRO6;ZTPJSBK2JM-EB-6]VQ1JT]K3.MZZVW69^Q?F3#LPFWD=MTVQRTN6D+ MVWK:9MDVVWY@>\%VUL[>+M%.9[?%[I3=(WN^?;1]A?V`_:?V#QRX#I$.:H"6[[;*;=SMOL!2(!4T"?8* M;KLSW*/<:]Q'W:]Z$#W$'I4>6SV^](0]@SS+/4<\+WK!7L%>:J^M7I>\"=ZA MWEKO4>\;0KHP1E@GW"N<\N'[I/IT^(S[//9U\2WTW>![UO>U7Y!?E=^8WRT1 M1Y0LZA`=$WWG[^DO]Q_QOQK`"$@(:`LX$O!MH%>@,G!;X)^#N$%I0:N"3@;] M(S@D6!^\/_A!B$M(22@A-#:T+?3CT!=AP6&&L(-A?P\7 MAE>&[PF_OT"P0+E@;,'="*<(6<2.B,E(++(D\OW(R2C'*%G4:-0WT<[1BNB= MT?=B/&(J8O;%/([UB]7'?A3[3!(F628Y'H?$)<9UQTW$<^)SXX?COTYP2E`E M[$V820Q*;$X\GD1(2DG:D'1#:B>52W=+9Y)#DIN2S=9$U:SJ69&GZ+?60O5+JD]8N#A/U,7C.[&E<:INLBZD;KG]7GUAQK8 M#=J&"XV>C6L:[S4E-/VF&6V6-Y]L<6QI;YE:%K-L1RO46MIZLLVYK;-M>GGB M\EWMU/;*]C]U^'7T=WR_(G_%L4Z[SN6==U=VMZ/ZBQZ]GL.>'7GGO%VM%:X?6_KBN;-U$7W#?MO7$]=KUUS=$ M;=C5S^YOZK^[,6WCX0%LH'O@^TW%F\X-!@YNWTS=;-P\.93Z3P"D`5O^F+B9 M))F0F?R::)K5FT*;KYP0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6 MHP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RL MT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;P MMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?! MX\)?PMO#6,/4Q%'$SL5+QHM\IWZ_@-N"]X43AS.)3XMOC8^/K MY'/D_.6$Y@WFENV<[BCNM.]`[\SP M6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^'1'4W1A=&4\/"]'4S$@,C<@ M,"!2/CX^/@UE;F1O8FH-,R`P(&]B:CP\+TQE;F=T:"`Q-C$T+T9I;'1E^?;_0 M8ME,CM/)VS3UA!;I]42[CNL)%_YXI-U81#",/9'>3-[.FE#D#:V[HLFK"6QR MW42D^62*P\"(]'[R6/)1,<\T*['`T$"I\;141**J7:T22*4AA)\E.6RE#___4]- MM?&=R)XY@`7:>G%DZ/0@B'I;W*"WQ>*A+Y10TU!^R&Z*1M37XKRXK3H8B`+<<;" M-PTH!\H;*:P;.K5&?F`D_%Z[F-43\`/Y%_*D:DL5.YH!"&4)P)Q6ZP.2<#]B)_<.!FW3OR:@9>+%?+S?TT!'O1^`RG3\AZP%/FJ99Q6J,2>H MJ[NB:16P7,L;,%`#AAY.\U;Q&SQ"F?%OJ]WOWR/6TVWI][>CDRYD+QY8<45(T%6D8J7&JNN%;/EV=S.EM:$ M;K-".!%6TH3\XSXBZ@Z5GV*\38P=GVTX7<@CH'""\?(9^"R^X+_Q(0/E])"5 MPN[C8_R.3/RBAJPZ(LTHFEZ.LJ1].-AN,YT/J`:0*\3B!,B4`%W)A(\-1BA, MGZH(O.#"REH9^8#$-O*)M*(/^F(,Q$[LO@@&`9]LR'`P=5:2X2T_OH/9'J4D MR/_-BB=O(4\#\^L-IKNS-8%O$!XDY12V),!F_&Z94;FNQA(S1"[H3JFK M?X;0HO=$.>`,9!,RD,_W303^.MO4=UP1*JX!H"54RM^WQ661BPLYRZJ,BLX5 M+V==C7C&2R_8`YB^\B6V]&QO+@NL^4!-L`L4`N`GI*%%#7$'D!4JD>(3I:D:E8ID2_,E_:\HAI=$ MSYK&]X@2$D-'(;:>,GA#)`X26H[X+:07S_0BY'^F-,0L$]U2^%:8O,"4;NDC>(,>A/#6">` M)GVU85G0:[E:^S!T]X';K16O%SA_"#2==('FVWB(N%H#?-3-+FI^7Q?B7=G< M\DO=E&UYQV/H:VO@'!(NB'T,D(`7WBAL3.U+0H4\&J^$'K\9?OR?`4V>`S3> M`133UE5G`R`!>0Q(3C,F";$*H45!0% MW-BDO3UQ-0"QY[S(=TW37[4JK@J0$L(#]7S:'?=<9W2PW,+9?M)=]"!K1V`) M9.T0OI@0;A![T7=-ZSW8IVL>F`F]&JR+^*^;5H5\7@ MS9$CN^IM(E^/W1:RVTJZ?9[7]]#7("%.ON7K[14Z2\M&S*A-T.PN:-?*BBHE M%@)\4M-PH'[366.?]6T(MPM)U_4OB@+NJM#-&;C+;+9Y"W<6?*F:OJ7:`VOD M^_3G4>$'EQN$B5P.5PEHYC0P<'0/>6V7B3X@K=9:@]40#CG"#_U(B]W9;)TU MU+$T'$:W@#F]%Q6[UMN-2-TW?)X%NBVH,[.,`)>COQ7>-),.Y[$#O5'0'6[` MW+U4&7L)#W&!/C6E:P`E,T_>TC6` M6EM*C105`24QW&L3682)C*AML5\PT^W>OPGN-6RF9[^MDF)^ M]&)PGZ23OP<`&ZX9>0H-"F5N9'-T'1=+T5X=$=3=&%T93P\+T=3 M,2`R-R`P(%(^/CX^#65N9&]B:@TV(#`@;V)J/#PO3&5N9W1H(#(U.#0O1FEL M=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB)K%=9<]LX$G[WK\#;@EN60A`\ M\V9[DJRG:I)LK)F:*CL/-`E9G$BDBH<=SZ_?/L##NB;9I%P6#@(-]/%]W7CU M[D:)A^;L;"F852.)\7O\*:F9HK/P$1OYSA4A4,NT+> M="=3QY\'\LX1[].-$\\]:1P/?D6U%->-$\U]V72F?LT2X;H^7U?/@\2+Z0"M MA@-F:9Q@'EHE4;]_ M-<()Y<>Z*/&FOBS`"$INT[5X\]7P%-SPT5!/?%@NB\PTWV`4ODK87\53='FX M:"QNVK0MJA+:VIB6]'GAL-GH,>QI5N*/M'1FZ+$,-/!DU?'HD1M#D_6YN*R+ MMFA6/"NN*NZL[>J-D\P3><^#(F4U%O_F*XXA8@/KC]`)Y(50E^&+L-)C6'F# M7V[EE:/1HXZ"$\HT3P<;64]-W6K]16Z51RSP(KR]`^&M)]8:[JZ#(;XIM$%5 MN3$"[2"7#MQ!2_'1U`U-E``!&*/DM\6Z*!]P\K5==<+%T6B!:#@9#8@GOT]; M$*MDEI886M?@&3CIT32M`ZA6X(,(?A%L,,U+Q6_0A&`[FDL?#.#1/[@04$+? MYHZ+6-W'B_Y^O(S0#0_C)2:\$$8*1,9E1]'&GQ`P6I:P4GR`"2T)(JAY50-H M0GDNBB4.RZJD;0:NCK,P]P8,8^1&UCK_T=?"H^\_0XOKF7T`J;?@+EC`7$R%D:^ MXMNH/A8RB(4K()6_(1S1-GBELED5VSU_N7NNHKL"FOP^M,3A&[O_=_#Z0_`F M_85SN/"B:-<&HQ:B[&KMQ#)MB.AAYL9D'9+D`1I_J<#.-?:-.L`^&[B`G%)M M*+T!20/)KU)`T<]);&.L^'ZOK$'O_'YS_=$)F=YO[`VG;?9&Q3Z@V86!* MI+<(J%!J/\%&Q0H;UQO9^)A6AQ4*@EWGL4)J0O::R?YZ*=I5T8@&\J79F+*E M69BX-T#58DFG*W_N!9`LW1,.*=8F%]NN1L**)*1"%X(O17FA;"OQJ8-043J? M*2*^<^8NJUPO?]M<9"N3?1%/ M*]8'R-$#:[K'*P'3KDP-IC%B:Q,9(*KDN@H/6?:I#"N`8C_*9_T9)R(""##Q MPUVV8J4YMUKGAK:(G2LWLK=^Z?T^_N9A'(=VP:#5K;P5GRDKB$NGMPS@YHNA MBK2V:806Y%2O`KO"P@387-2\Z*&@"4BO/,^SO%ITU)3Y1![@GY?RO@I)-J!2 M("#SJ8"[%35+C!9(@"U53BM>3.GMPHKI`V4>)9"/=BSF60Q!9%%R!+M99XR& M0XR?-)SVHXGA!L9S+6;8A(I-&%$5H4@?7W[!^P)0TX;(6Y`=%"B%ZPNR>`G8 M*$"Y&$.(%C=LH-@NJ$@2U3(:7PTH`-0@$$%THZ20=\(LW8-W+'D)62YFRX53 MR\6'+*=W8HU#DH#R`P%WI,X!PT%!Q65,A\A4LDZI9H%J1&34JWB>"%W++8_2 M\AE,BJKD9LD5#)J1`0QTZ(7)Y&!OK*Q[KBC`UA34:.NBXD$I-'?`J@1>0-F= M5(F=="RB,:D!#[8KGC<"S-E;$D+,TT>"T!WRXT^(Q),6Q5K7&HR+/4O=6;5O MQMJ0F1^*I@7HYJ(#K!),V3(4=K'-W$!YM%@<**8FEB:JM-1_W;,C@OC16HQ! MC'=,QJ'U2,N%]97U"2_9\B"U:Y[%!8H%A7AK"SZQSD'^X$4)E(_LXV^/G+!;'^"RAZ`7RI/<&E;Z:7AM`&CF]2AZA-`9OU"P$ M!R7-BY2V9EG%GW(6S+/V%'X(/.$F%+GBC9^(-SM>LH9Y/I6,IVE)/B.1B@8( M!Q>([9Y'#H=O_Q$@@N+Q?_CT!K/M/[+R`(BE$QZ`PTFKD]3!ZA,@^",0+DIA M*.`#N5U7S\9`X0+QBY2[+*CXV*[YC0@6).KPYD$<3G,_EV`D.+8%M"GSZHG$ MPI,&@+4$Q(BB%"DZ(D^1N7K=K;B]LFXH*`*6^82!"OD0*27$*/[4<8?K(N[/ M%+>8R;B#Y#1V40:DC`)Y*N#"A]JW4.K'LI\]"88=MSS\K(P9CYC04TP$C`D( M]2U&;2"I=@@H_!&X&*Z<_V(,4ZPJ"FJ@NL(Y082FF2`4$<0SOBUC3H%8S<"I M<$I&8BLKMZ:C*]["]"W^EGIR!M0 MJ/MTA*P,[@4LBB8E^L>R)T2">N!1`XF\J;B?%:E-QE`_C0F>A12@H.8L`7SIL\.]7@/&V= M]XO9TEL`2F%@E^O2]CMNZ]1.9'T)=M1'T]QN$U.QFYB@LO/=TQ09!Z$^]8PA MBH3'3U=G*['E_+D&WR22KQJPH:@0:N$=(\Q7'F6\JLMY"$7#LK:OH`U5Z<,^ M([`^L](*8=C/>RN*KOMA&Q/NVV`ZYV/8I[T72IV3G M,]-$7&R'6&RC@!4?:6B[N*:%G.I].5P\VKOW@5@;<<5FL,"ZH@J_X@J?]`Q0 M3Y><]\RO@`O2*>A#G]A?T:>$?GWW>R+PKQ^/0"\:^,X;^"%`=GA78Z?JJ,Z+ MY#E0+[8E#RFU^!%KE[Z#OTBF MW/O5F7E]LNPY-)Q[[D,I'DNF^UZ`(U]K'R!"W?WYFC\!5KZUSV%TK M=F-!@\;!-PI_2%O,;0`JZV]36O].EBZYOZ9?#*Y8YI3;.G(Y)#AX::7]1BO0 MAI$M_W`=E7\Q6@T1$%L$>/*H]U M)L_%,!H<%]J?.WP5B@OR`>"J(UO"_.5@\H3J2YK-N$G7U/#OL\,)&J]-5GYB MVY9(#XG,7Z-%Z33EJRB!&`[0[-`DM#/B44@#SS_$&3L:OEF<_6\`R5>(X`H- M"F5N9'-T2A!'1= M+T5X=$=3=&%T93P\+T=3,2`R-R`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:CP\ M+TQE;F=T:"`R-S,U+T9I;'1E/KX^YO++0Z#6W>33?'(YG\FWB!DV1,]C?E M_CG_Y\17H`[B/%7SSYC0U72KH]SY?^QF))LD4CH(EYT*5T(N#.[=&!+M2:+( M>72#$!531J=[-0=_(-K$[;*J2:3:J@ M,IS-XI%PIUO<;'DUM=H4I/M/-0R]61[/QA13TBX8G!`%IWI6T)-&Z@%BQKAK MJ]6N.4"YWBS0[I,9]UHU+2TL95Y!O,QI==FK?B-+6AV)R5M9$.2@263MP@V] MW$YR-X"*Z7AG%LHLMG>/-([>\VD^^%1T9;7]L?;TS%)-')W,KC[S``5^5MS('C/SO._OX4LP=03`,4^_PMXHM\#;67()'*:$#'"%`.H,_2= M0.7C`,,N5LA[=+YCN].!WL0`+AIIGSKT.M.1&VW:;:\1*2ZJ_5DT950$&H M>TXX6/Y-Z+K.$A52$6"+#))SR1")C_5*Q(F"GR<."9MP@&UJ1%TQ3$.'DUOH M5)WJ^@+RP[:8:H@"L]:RV2MLPZ8+F6HR*FQ>KV6N5M56+\VX;U2K);)"I^U% M\`"J4,3X9]:SV".)^@U[=U5PRBUZE!FV`-6BGB'"$148$$!6M3$6E@_HW-F` M?7/C60H=71L?KV4&&?)%VT,I4Z4ZP1'*$W$M-7_UDA1<:-$J]M(X3-[52AFU M%B)CK5=5615;U0`>K82[@LTI.3:B7JN5U<'P?Y$$X\&;N56"[(VXK.7+AJR> M9*(EJ';C&0%0YKW8-W4,"ZU*`M^0"V/$$-?N3I?[%AE+=ZKT&0[$[!E.8B%/\H;+EQ_QC_/)-BC?__GF&_L#+@UEHCI]7CC#U M_%F2CSW_T6`>.XYC&7?//'46RH*SNZ9EQP*J-<*:`)P.5&Z)/>%%OP26#QR`#_NFX`("%57_%!]!$RK\X3PM3>^-&\<)H6;#F] M+WHN*&7!X+]%$D5Q>M(=-7PS](ED!@VG8E4HU1UH`E0$7BO6U"GFKQ+>UB7O M>90^`"@$.F\PUM!3`KR<02I>E0G?'/'-*,;$<4JW69;%4JCD2`?V@=09M&ZV M"(24Q6A%,I@D,)*+K#VTX8%CH@X548(L&H+,--`,[XC#`;CG1$EZ3WV6EO>> M76[H*S/M^JK?RY`K?2QO`/J8!WK#-[!\?):P#DDPPG(J MCPHN,K=+W)G`!GVUXG<`#`B?DY!B^RGI!H\LF8K/W&S='&[JJA5W^JP"OV:& M0PQ\(#6SL3FU[P\C3V2*#Z<`+&>L$*HJ@E*%D6909&MH6$6G'0&;-UO>#E2MF-()`[S M`&KN].,""1"&BQW;+EDD?6GY1+/?O;2;N87MEOZ5Y/B&X?Z7`#UF%C\\K36Y M)QW//:==!D8*U7%IBD+A4DEP)05-$9V?9:/KN(]CG*7.GA-O3P2R;;C4O'YR M'O;*8"W>>&&RCS>8_R^0';$@N6QD*F1>=:/1K"%F%W;2*;5M42PM'G(DM9W"9Y!G')O::N$P*Z\`B.1 MVC_RE9V-G"HX%;N>6[R-L<)"?) ML>6:%[74W\196CV.LFJ4O-!97;R"^^G15)QHQ_TH,:6N4<:F=VSU2K5DRYAL5X4?#K M-A:GI.+TV?&M*YWZH>(6JN??C:E!)S/#1*_XS$J7LBOO!^%3;@HFJOFBM;`T M$\.2;Z5?N\G+JRW/]G)'79ZR[D%M-;]G9;7@^H+$659VI99O M#SF5G3S#S3!8W]J%SM9J/\GSL>6RP7(F\M'45Z)G=K0)*CY7M">95"ZWS&M# MU5L:?@CM]C)K*784HH0;?H(^#\P'MO.LH8Q4X]`\R^T`VGFI02<5Y\%YO0EF MDO,?;K_<<_Z\GG,Z__?OO_#WM8;,LAG7E5=*BB2K`>F10?HUZ9.*6JC;@'LK M0UUT9,>$&NW%5C.,:,*YC3IV0_74YAWE*QW492Z$W6[CX+*>!E49,VMPS`^DFCKA/VI))+*:Y-J;]CMQ:R5JREH+]" M"(\)-^D;RC=E?T5:`6XP`-&"5S[+,HW?2E;KL+M4-HPX%H<+#MY9QH>ZJ M;2/CVGQWS5X&VT82RR_S211"7)7G7H;0\O%1<%*:YQD:ALEJ\FD^@==\>E?Z M2D9QA%#V`R^&,=7\\87MIU'H15$2O0C"E^D>NH2H/>#ES*M^JZ_476'2<4$6 M"YVU3>T\:R_4;WI]0K!5UZM54;7=FVWN*X&0#H*8YN&S9#?BB5QPI7[5"T%H M*FL4FMC.60G/SX*/#]A9&]B92UX87`M M9FEL=&5R&UL;G,Z>#TG861O M8F4Z;G,Z;65T82\G('@Z>&UP=&L])UA-4"!T;V]L:VET(#(N.2XQ+3$S+"!F M&UL;G,Z:5@] M)VAT='`Z+R]N&UL;G,Z>&%P/2=H='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O)R!X87`Z0W)E871O&%P.D-R96%T941A=&4])S(P,#@M,#(M,3E4,3(Z,#@Z,SDM,#4Z M,#`G/CPO&%P34TZ1&]C=6UE;G1)1#TG=75I9#IA,3ED.6%F.2TS-65C+31D M,3(M8F%B8BTV,6,Y8F4T-F0S.3,G+SX-"CQR9&8Z1&5S8W)I<'1I;VX@&UL;G,Z9&,])VAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL.FQA;F<])W@M9&5F875L="<^36EC#IX;7!M971A/@T*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H\/WAP86-K970@96YD/2=W)S\^#0IE;F1S=')E M86T-96YD;V)J#3$V(#`@;V)J/#PO36]D1&%T92A$.C(P,#@P,C$Y,3(P.#,Y M+3`U)S`P)RDO0W)E871I;VY$871E*$0Z,C`P.#`R,3DQ,C`X,SDM,#4G,#`G M*2]4:71L92A-:6-R;W-O9G0@5V]R9"`M($%N9VEO=&5C:%\P-S$R,S$N9&]C M*2]#')E9@T* ,,3$V#0HE)45/1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----